Cargando…

The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions

Background. The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) is an expert consensus guideline for depressive disorder created in 2002, and since then, four revisions (2006, 2012, 2017, 2021) have been published. In this study, changes in the content of the KMAP-DD survey and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Seung-Ho, Bahk, Won-Myong, Woo, Young Sup, Seo, Jeong Seok, Park, Young-Min, Kim, Won, Jeong, Jong-Hyun, Shim, Se-Hoon, Lee, Jung Goo, Jon, Duk-In, Min, Kyung Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917906/ https://www.ncbi.nlm.nih.gov/pubmed/36769798 http://dx.doi.org/10.3390/jcm12031146

Ejemplares similares

Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision
por: Woo, Young Sup, et al.
Publicado: (2018)

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision
por: Seo, Jeong Seok, et al.
Publicado: (2018)

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
por: Wang, Hee Ryung, et al.
Publicado: (2017)

Korean Medication Algorithm Project for Bipolar Disorder: third revision
por: Woo, Young Sup, et al.
Publicado: (2015)

Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2019)

Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary
por: Seo, Jeong Seok, et al.
Publicado: (2021)

The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines
por: Woo, Young Sup, et al.
Publicado: (2022)

Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary
por: Woo, Young Sup, et al.
Publicado: (2022)

Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2023)

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
por: Wang, Hee Ryung, et al.
Publicado: (2014)

Effect of Initial Ziprasidone Dose on Treatment Outcome of Korean Patients with Acute Manic or Mixed Episodes
por: Woo, Young Sup, et al.
Publicado: (2011)

The Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients
por: Kim, Won, et al.
Publicado: (2011)

Prevalence of bipolar spectrum disorder in Korean college students according to the K-MDQ
por: Bae, Seung Oh, et al.
Publicado: (2013)

Screening with the Korean Version of the Mood Disorder Questionnaire for Bipolar Disorders in Adolescents: Korean Validity and Reliability Study
por: Shim, Se-Hoon, et al.
Publicado: (2018)

Predictors of a Shorter Time to Hospitalization in Patients with Bipolar Disorder: Medication during the Acute and Maintenance Phases and Other Clinical Factors
por: Shim, In Hee, et al.
Publicado: (2017)

Validation of the Korean Version of the Depression in Old Age Scale and Comparison with Other Depression Screening Questionnaires Used in Elderly Patients in Medical Settings
por: Jung, Young-Eun, et al.
Publicado: (2019)

Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Seo, Jeong-Cheol, et al.
Publicado: (2022)

Corrigendum: Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Seo, Jeong-Cheol, et al.
Publicado: (2022)

Improving the Screening Instrument of Bipolar Spectrum Disorders: Weighted Korean Version of the Mood Disorder Questionnaire
por: Hong, Narei, et al.
Publicado: (2018)

The Impact of COVID-19 on Psychiatric Health in the Korean Population
por: Wang, Sheng-Min, et al.
Publicado: (2023)

Developing the Korean Association of Medical Colleges graduate outcomes of basic medical education based on “the role of Korean doctor, 2014”
por: Kim, Min Jeong, et al.
Publicado: (2018)

Psychometric Properties of the Hypomania Checklist-32 in Korean Patients with Mood Disorders
por: Yoon, Bo-Hyun, et al.
Publicado: (2017)

Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression
por: Shim, In Hee, et al.
Publicado: (2017)

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
por: Shim, In Hee, et al.
Publicado: (2018)

KMAP-O framework for care management research of patients with type 2 diabetes
por: Wan, Thomas T H, et al.
Publicado: (2017)

Prevalence and Comorbidities of Adult Attention-deficit/ hyperactivity Disorder in a Community Sample from Korea
por: Woo, Young Sup, et al.
Publicado: (2023)

Bioequivalence of Generic and Brand Name Clozapine in Korean Schizophrenic Patients: A Randomized, Two-Period, Crossover Study
por: Woo, Young Sup, et al.
Publicado: (2015)

Clinical assessment of bipolar depression: validity, factor structure and psychometric properties of the Korean version of the Bipolar Depression Rating Scale (BDRS)
por: Jung, Young-Eun, et al.
Publicado: (2016)

Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
por: Jeong, Jong-Hyun, et al.
Publicado: (2013)

Predictive Analytics for the KMAP-O Model in Design and Evaluation of Diabetes Care Management Research
por: Wan, Thomas T.H.
Publicado: (2021)

Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2016)

Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review
por: Woo, Young Sup, et al.
Publicado: (2020)

Psychometric Properties of the Korean Version of Functioning Assessment Short Test in Bipolar Disorder
por: Kang, Hangoeunbi, et al.
Publicado: (2023)

Factors associated with bullying victimization among Korean adolescents
por: Seo, Hye-Jin, et al.
Publicado: (2017)

Lurasidone as a potential therapy for bipolar disorder
por: Woo, Young Sup, et al.
Publicado: (2013)

Ginkgo biloba induced mood dysregulation: a case report
por: Rho, Seung Sun, et al.
Publicado: (2018)

PS106. Nicotinic acetylcholine receptor antagonists for treatment-resistant depression: A meta-analysis.
por: Wang, Hee Ryung, et al.
Publicado: (2016)

PS150. Comparative efficacy of various augmentation strategies for treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Wang, Hee Ryung, et al.
Publicado: (2016)

Naltrexone-associated Visual Hallucinations: A Case Report
por: Lee, Dae Bo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qqbruojlf3pc7tmrchkirjobq1